XML 143 R117.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SHARE CAPITAL (Details Narrative) |  |  |  |  |  |  |  |  |  |  |  |  | 12 Months Ended |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 09, 2024 USD ($) shares | Aug. 02, 2023 USD ($) $ / shares shares | Mar. 30, 2023 USD ($) $ / shares shares | Feb. 21, 2023 USD ($) $ / shares shares | Feb. 21, 2023 CNY (¥) | Jan. 13, 2023 USD ($) $ / shares shares | Jan. 10, 2023 USD ($) $ / shares shares | Oct. 04, 2022 USD ($) $ / shares | Sep. 30, 2022 USD ($) Investors $ / shares shares | Jun. 14, 2021 USD ($) $ / shares | Jun. 10, 2021 USD ($) Investors $ / shares shares | Feb. 17, 2021 USD ($) $ / shares | Feb. 12, 2021 USD ($) $ / shares shares | Dec. 31, 2023 CNY (¥) shares | Dec. 31, 2022 CNY (¥) shares | Dec. 31, 2021 CNY (¥) shares | Jan. 29, 2024 shares | Dec. 31, 2023 $ / shares shares | Dec. 31, 2023 ¥ / shares shares | Feb. 21, 2023 ¥ / shares shares | Sep. 03, 2020 ¥ / shares shares | Sep. 02, 2020 shares
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Authorized issued share capital | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 58,929,000 | ¥ 5,724,000 | ¥ 29,586,000 |  |  |  |  |  |
Number of shares authorized |  |  |  | 977,755 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 977,755 |  |
Par value per share | $ / shares |  |  |  |  |  | $ 0.024 | $ 0.024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number oif shares sold |  | 2,083,333 | 5,681,820 |  |  | 1,234,568 | 1,625,000 |  |  |  |  |  |  |  | 166,667 |  |  | 1,062,472 | 1,062,472 |  |  |
Preferred shares issued capital |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 |  |  | 50,000,000 | 50,000,000 |  |  |
Number of shares outstanding |  |  |  | 10,035,188 |  |  |  |  |  |  |  |  |  |  | 805,785 | 597,610 |  | 3,251,917 | 3,251,917 | 10,035,188 | 3,100,000 | 9,200,000
Aggregate the number of share sale |  |  |  |  |  |  |  |  |  |  |  |  | 588,235 |  |  |  |  |  |  |  |  |
Purchase price of per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 3.57 |  |  |  |  |  |  |  |  |
Gross Proceeds from pricing of public offering | $ |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,100,000 |  |  |  |  |  |  |  |  |
Warrant life |  |  |  |  |  |  |  |  |  |  |  | 5 years | 5 years |  |  |  |  |  |  |  |  |
Proceeds from offering | $ |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,860,000 |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares sold in offering |  |  |  |  |  |  |  |  |  |  |  |  | 5.00% |  |  |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 4.46 |  |  |  |  |  |  |  |  |
Warrants exercisable term |  |  |  |  |  |  |  |  |  |  |  |  | 6 months |  |  |  |  |  |  |  |  |
Number of institutional accredited investors | Investors |  |  |  |  |  |  |  |  | 2 |  | 3 |  |  |  |  |  |  |  |  |  |  |
Grant date |  |  |  |  |  |  |  | October 4, 2022 |  | June 14, 2021 |  | February 17, 2021 |  |  |  |  |  |  |  |  |  |
Share price at date of grant | $ / shares |  |  |  |  |  |  |  | 0.58 |  | 3.15 |  | 4.45 |  |  |  |  |  |  |  |  |  |
Volatility |  |  |  |  |  |  |  |  |  |  |  | 107.00% |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  | 0.00% |  | 0.00% |  | 0.00% |  |  |  |  |  |  |  |  |  |
Risk-free interest rate |  |  |  |  |  |  |  | 3.96% |  | 0.80% |  | 0.57% |  |  |  |  |  |  |  |  |  |
Average fair value at grant date | $ |  |  |  |  |  |  |  | $ 0.43 |  | $ 2.50 |  | $ 3.54 |  |  |  |  |  |  |  |  |  |
Share issued price per share | (per share) |  | $ 0.48 | $ 0.88 |  |  | $ 0.81 | $ 0.80 |  |  |  |  |  |  |  |  |  |  | $ 1.00 | ¥ 7.10 |  |  |
Proceeds from issuing shares | $ |  | $ 1,000,000 | $ 5,000,000 |  |  | $ 1,000,000 | $ 1,300,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of voting rights held in associate |  |  | 15.15% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 700,516 |  |  |  |  |  |
Warrants exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 70,867 |  | 685,339 |  |  |  |  |  |
Warrants exercised cashless |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 32,677 |  |  |  |  |  |
Shares issued upon cashless exercise of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,500 |  |  |  |  |  |
Warrants exercised | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 10,258,000 |  |  |  |  |  |
Bottom of range [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value per share | ¥ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0.008 |
Exercise price at date of grant | $ / shares |  |  |  |  |  |  |  | $ 0.82 |  | $ 3.42 |  | $ 3.57 |  |  |  |  |  |  |  |  |  |
Top of range [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value per share | ¥ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0.024 |
Warrant life |  |  |  |  |  |  |  | 5 years |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |
Exercise price at date of grant | $ / shares |  |  |  |  |  |  |  | $ 0.75 |  | $ 4.35 |  | $ 4.46 |  |  |  |  |  |  |  |  |  |
Volatility |  |  |  |  |  |  |  | 104.00% |  | 115.00% |  |  |  |  |  |  |  |  |  |  |  |
Investor warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant life |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |
Proceeds from offering | $ |  |  |  |  |  |  |  |  | $ 1,000,000 |  | $ 3,180,285 |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  |  |  |  |  |  |  |  | $ 0.82 |  | $ 3.42 |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase shares of common stock |  |  |  |  |  |  |  |  | 1,666,667 |  | 913,875 |  |  |  |  |  |  |  |  |  |  |
Placement agent warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares sold in offering |  |  |  |  |  |  |  |  | 5.00% |  | 5.00% |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  |  |  |  |  |  |  |  | $ 0.75 |  | $ 4.35 |  |  |  |  |  |  |  |  |  |  |
Securities purchase agreement [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number oif shares sold |  |  |  |  |  |  |  |  | 1,666,667 |  | 913,875 |  |  |  |  |  |  |  |  |  |  |
Purchase price of per share | $ / shares |  |  |  |  |  |  |  |  | $ 0.60 |  | $ 3.48 |  |  |  |  |  |  |  |  |  |  |
Securities purchase agreement [member] | Investor warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Closing price for the common shares preceding execution of the SPA | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 3.42 |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 110,343 | 33,269 |  | 29,234 | 29,234 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | 639,000 | ¥ 621,000 | ¥ 573,000 |  |  |  |  |  |
Chief Executive Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 268,331 | 81,010 |  | 171,338 | 171,338 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,432,000 | ¥ 1,490,000 | ¥ 1,262,000 |  |  |  |  |  |
Employee [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 36,408 |  |  | 719,428 | 719,428 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | 19,070,000 | ¥ 69,000 |  |  |  |  |  |  |
Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 168,000 | 168,000 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,037,000 |  |  |  |  |  |  |  |
Employees [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 224,793 | 224,793 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 17,282,000 |  |  |  |  |  |  |  |
Class A ordinary shares [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |  | 200,000,000 | 200,000,000 |  |  |
Number oif shares sold |  |  |  | 200,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |
Class B ordinary shares [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 |  |  | 50,000,000 | 50,000,000 |  |  |
Number oif shares sold |  |  |  | 50,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 |  |
Memorandum and articles of association [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Authorized issued share capital | ¥ |  |  |  |  | ¥ 4,800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  | 200,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |
Par value per share | ¥ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0.024 |  |
Number oif shares sold |  |  |  | 250,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |
Weilai will zhang [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of voting rights held in associate |  |  | 52.13% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nonadjusting event [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  | 977,755 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 977,755 |  |
Preferred shares issued capital |  |  |  | 50,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 |  |
Aggregate of warrants | 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of shares issued | $ | $ 190,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nonadjusting event [member] | Mrweilai zhang [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares outstanding |  |  |  | 977,755 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 977,755 |  |
Nonadjusting event [member] | Class A ordinary shares [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  | 200,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |
Nonadjusting event [member] | Class B ordinary shares [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  | 50,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 |  |
Number oif shares sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 300,000 |  |  |  |  |
Nonadjusting event [member] | Memorandum and articles of association [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Authorized issued share capital | $ |  |  |  | $ 4,800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized |  |  |  | 200,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |
Par value per share | $ / shares |  |  |  | $ 0.024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number oif shares sold |  |  |  | 250,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |

X
- Definition Aggregate of warrants. + References No definition available. + Details
Name: | AEHL_AggregateOfWarrants
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate the number of share sale. + References No definition available. + Details
Name: | AEHL_AggregateTheNumberOfShareSale
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Closing price for common shares preceding execution of spa. + References No definition available. + Details
Name: | AEHL_ClosingPriceForCommonSharesPrecedingExecutionOfSpa
Namespace Prefix: | AEHL_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of risk free interest rate warrant granted. + References No definition available. + Details
Name: | AEHL_DescriptionOfRiskFreeInterestRateWarrantGranted
Namespace Prefix: | AEHL_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected dividend yield percentage warrant granted. + References No definition available. + Details
Name: | AEHL_ExpectedDividendYieldPercentageWarrantGranted
Namespace Prefix: | AEHL_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents the fair value of shares. + References No definition available. + Details
Name: | AEHL_FairValueOfSharesIssued
Namespace Prefix: | AEHL_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gross proceeds from pricing of public offering. + References No definition available. + Details
Name: | AEHL_GrossProceedsFromPricingOfPublicOffering
Namespace Prefix: | AEHL_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | AEHL_IfrsStatementLineItems
Namespace Prefix: | AEHL_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of institutional accredited investors. + References No definition available. + Details
Name: | AEHL_NumberOfInstitutionalAccreditedInvestors
Namespace Prefix: | AEHL_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of warrants exercised. + References No definition available. + Details
Name: | AEHL_NumberOfWarrantsExercised
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of warrants exercised cashless. + References No definition available. + Details
Name: | AEHL_NumberOfWarrantsExercisedCashless
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of aggregate number of shares sold in offering. + References No definition available. + Details
Name: | AEHL_PercentageOfAggregateNumberOfSharesSoldInOffering
Namespace Prefix: | AEHL_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Preferred shares authorized capital. + References No definition available. + Details
Name: | AEHL_PreferredSharesAuthorizedCapital
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Proceeds from offering. + References No definition available. + Details
Name: | AEHL_ProceedsFromOffering
Namespace Prefix: | AEHL_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Purchase price of per share. + References No definition available. + Details
Name: | AEHL_PurchasePriceOfPerShare
Namespace Prefix: | AEHL_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share issued price per share. + References No definition available. + Details
Name: | AEHL_ShareIssuedPricePerShare
Namespace Prefix: | AEHL_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the number of shares issued upon cashless exercise of warrants. + References No definition available. + Details
Name: | AEHL_SharesIssuedByCashlessExerciseOfWarrants
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shares issued by exercise of warrants. + References No definition available. + Details
Name: | AEHL_SharesIssuedByExerciseOfWarrants
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant life. + References No definition available. + Details
Name: | AEHL_WarrantLife
Namespace Prefix: | AEHL_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant number of securities called by warrants or rights. + References No definition available. + Details
Name: | AEHL_WarrantNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | AEHL_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants exercisable term. + References No definition available. + Details
Name: | AEHL_WarrantsExercisableTerm
Namespace Prefix: | AEHL_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants exercise price per share. + References No definition available. + Details
Name: | AEHL_WarrantsExercisePricePerShare
Namespace Prefix: | AEHL_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2023-03-23 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares authorised. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 79 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfSharesAuthorised
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 79 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfSharesOutstanding
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the exercise of share purchase warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProceedsFromExerciseOfWarrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProceedsFromIssueOfOrdinaryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The proportion of the voting rights in an associate held by the entity. [Refer: Associates [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph 21 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProportionOfVotingPowerHeldInAssociate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=AEHL_InvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=AEHL_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | AEHL_CollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=AEHL_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=AEHL_EmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=AEHL_EmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=AEHL_ClassAOrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=AEHL_ClassBOrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=AEHL_MemorandumAndArticlesOfAssociationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=AEHL_WeilaiWillZhangMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=AEHL_NonadjustingEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=AEHL_MrWeilaiZhangMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |